Debt-to-equity of TriSalus Life Sciences, Inc. from 30 Sep 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TriSalus Life Sciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 31 Dec 2025.
  • TriSalus Life Sciences, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was -224%, a 16% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TriSalus Life Sciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 -224% -31% -16% 31 Dec 2025
Q3 2025 -223% -30% -16% 30 Sep 2025
Q2 2025 -221% +11% +4.8% 30 Jun 2025
Q1 2025 -205% -148% -259% 31 Mar 2025
Q4 2024 -192% -166% -628% 31 Dec 2024
Q3 2024 -192% -176% -1092% 30 Sep 2024
Q2 2024 -232% -222% -2084% 30 Jun 2024
Q1 2024 -57% -46% -420% 31 Mar 2024
Q4 2023 -26% -15% -123% 31 Dec 2023
Q3 2023 -16% -6.3% -64% 30 Sep 2023
Q2 2023 -11% +4.1% +28% 30 Jun 2023
Q1 2023 -11% +13% +55% 31 Mar 2023
Q4 2022 -12% +32% +73% 31 Dec 2022
Q3 2022 -9.8% +97% +91% 30 Sep 2022
Q2 2022 -15% 30 Jun 2022
Q1 2022 -24% 31 Mar 2022
Q4 2021 -44% 31 Dec 2021
Q3 2021 -107% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.